Form D — FibroBiologics, Inc.
0001493152-26-031095 · filed Jun 29, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $3,000,000
- Reported amount sold
- $3,000,000
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $315,000
- Finders' fees
- $0
Issuer
- Name
- FibroBiologics, Inc.
- CIK
- 1958777
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 9350 KIRBY DRIVE
HOUSTON, TX 77054 - Phone
- 281-671-5150
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Pete O'Heeron · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Robert Hoffman · DirectorHouston, TX Find on LinkedIn ↗
-
Matthew Link · DirectorHouston, TX Find on LinkedIn ↗
-
Victoria Niklas · DirectorHouston, TX Find on LinkedIn ↗
-
Richard C. Cilento · DirectorHouston, TX Find on LinkedIn ↗
-
Jason D. Davis · Executive OfficerHouston, TX Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗